EDGAR Filing Documents for 0001104659-22-116578

Form 8-K - Current report:

SEC Accession No. 0001104659-22-116578

Filing Date

2022-11-09

Accepted

2022-11-09 17:22:22

Documents

Period of Report

2022-11-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2230161d1_8k.htm iXBRL	8-K	42133
2	EXHIBIT 10.1	tm2230161d1_ex10-1.htm	EX-10.1	137594
3	EXHIBIT 10.2	tm2230161d1_ex10-2.htm	EX-10.2	71893
4	EXHIBIT 10.3	tm2230161d1_ex10-3.htm	EX-10.3	45733
5	EXHIBIT 99.1	tm2230161d1_ex99-1.htm	EX-99.1	11048
10	GRAPHIC	tm2230161d1_ex99-1img01.jpg	GRAPHIC	59071
11	GRAPHIC	tm2230161d1_ex99-1img03.jpg	GRAPHIC	692
	Complete submission text file	0001104659-22-116578.txt		684255

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	nrxp-20221104.xsd	EX-101.SCH	3508
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	nrxp-20221104_def.xml	EX-101.DEF	26545
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	nrxp-20221104_lab.xml	EX-101.LAB	36481
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	nrxp-20221104_pre.xml	EX-101.PRE	25169
13	EXTRACTED XBRL INSTANCE DOCUMENT	tm2230161d1_8k_htm.xml	XML	5268

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801

Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134

NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)